June 29, 2020 / 2:08 AM / 10 days ago

BRIEF-Cansino Biologics Says Recombinant Novel Coronavirus Vaccine Got Military Specially-Needed Drug Approval

June 29 (Reuters) - Cansino Biologics Inc:

* RECOMBINANT NOVEL CORONAVIRUS VACCINE GOT MILITARY SPECIALLY-NEEDED DRUG APPROVAL WITH A VALID PERIOD FOR 1 YEAR

* APPROVAL RECEIVED FROM HEALTH BUREAU OF LOGISTICS SUPPORT DEPARTMENT OF CENTRAL MILITARY COMMISSION ON JUNE 25 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below